John J. McGrath III

John J. McGrath III

John J. McGrath III
+1 445 207 7803

John J. McGrath is a partner in the Private Equity group at Goodwin. He joined the firm in 2023.

John represents clients in the healthcare, technology, and other industries in connection with a variety of business transactions, including without limitation, mergers and acquisitions, strategic joint ventures and capital raises. He counsels clients on corporate governance issues, securities matters, financings, commercial contracts and other legal and transactional matters from entity formation through dissolution.

John represents private equity firms and their portfolio companies, investors, health systems, physician groups, retail, specialty and long-term care pharmacies, long-term care facilities (including skilled nursing and assisted living facilities), group purchasing organizations, and other health care and non-healthcare clients on a variety of transactions and other legal matters. He works closely with the firm’s health care regulatory experts to counsel clients on regulatory issues under fraud and abuse laws (including the federal Anti-Kickback statute and related safe harbors), the Stark Law, the federal False Claims Act, HIPAA, corporate practice of medicine, and other applicable laws and regulations applicable to the healthcare industry.

Before joining the firm, John represented public and private, for-profit and nonprofit, health care and non-health care clients in a broad corporate and transactional practice, including transactions and other matters including domestic and cross-border mergers, acquisitions and divestitures, corporate governance issues and the negotiation and drafting of commercial agreements.


Representative matters include:

  • Sale of dental practice/management company ($100 million)*
  • Sale of women’s healthcare provider ($100 million)*
  • Sale of a urology-focused group purchasing organization to a private equity firm ($115 million)*
  • Expansion of a Texas-based long-term care organization through numerous strategic acquisitions of skilled nursing facilities, assisted living facilities, pharmacies, and hospice facilities ($45 million - $205 million)*
  • Merger and subsequent sale of two long-term care pharmacy market leaders (combined enterprise value of more than $100 million)*
  • Reorganization of a preeminent urology practice and the sale of its management company ($115 million)*
  • Expansion of a national behavioral health pharmacy through numerous strategic acquisitions of numerous specialty pharmacies and a telepsychiatry service provider ($2 million - $50 million)*
  • Acquisition and disposition of numerous retail, compounding, and specialty pharmacies (in excess of $25 million)*
  • Acquisitions and dispositions of multiple healthcare providers (in excess of $25 million)*
  • Acquisitions of numerous home health and hospice providers*
  • Representation of a regional health system in connection with its affiliation with another health system*
  • Representation of a regional health system (in excess of $25 million) in connection with its affiliation with another health system*
  • Sale of a regional elevator installation and repair company*
  • Numerous acquisitions by a global pharmaceutical packaging manufacturer:*
    • $40 million acquisition of pharmaceutical packaging companies with operations in the United States, Ireland and Puerto Rico*
    • $33 million acquisition of a paper and plastics manufacturing company*
    • $33 million acquisition of global manufacturers and distributors of pharmaceutical packaging products with locations in the United States, Puerto Rico and Poland*
    • $18 million (Canadian) acquisition of a manufacturer of plastic packaging products located in Canada*
    • $5 million acquisition of a manufacturer of polyethylene and other films and bags located in the United States*
    • $5 million acquisition of manufacturers of pharmaceutical packaging products located in Puerto Rico*
  • Numerous transactions by a publicly traded global leader in shrink management, merchandise visibility and apparel labeling:*
    • $80 million acquisition of a manufacturer and distributor of merchandise identification and shrink management products with operations in the United States, Asia, Europe and Latin America*
    • $150 million acquisition of a global manufacturer of retail shrink management products*
    • disposition of a division specializing in retail security products and services*
  • Acquisition by a subsidiary of a publicly traded company by merger with a human resources consulting company with operations in the United States, Europe, the Middle East, Australia, New Zealand, and Singapore ($36 million)*
  • Internal reorganizations by, and divestitures of, subsidiaries of a publicly traded water and wastewater utility company in the business of water management and infrastructure repair*

* Denotes experience prior to joining Goodwin.

Professional Activities

  • Member, American Health Lawyers Association

Professional Experience

Before becoming an attorney, John was an institutional participant services associate with The Vanguard Group, where he assisted defined contribution and defined benefit plan participants with investment and plan education, tax issues and account problem resolution. During law school, he was an intern with then Delaware Supreme Court Justice Myron T. Steele.




Temple University Beasley School of Law


The Pennsylvania State University



  • Pennsylvania


  • U.S. District Court for the Eastern District of Pennsylvania


  • Speaker, “State of the Healthcare M&A Industry,” 14th Annual ‘Investment and M&A Opportunities in HEALTHCARE’ Conference, September 14, 2022
  • Panelist, “State of the Market: Trends and Issues in Health Care and Life Sciences Transactions,” ACC Greater Philadelphia In-House Counsel Conference, May 4, 2022